{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:58:15Z","timestamp":1793642295777,"version":"4.5.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.apradiso.2025.111671","type":"journal-article","created":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T06:37:18Z","timestamp":1736663838000},"page":"111671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["\u201cNanoparticle-based sensitizers in prostate cancer treatment: Enhancing radiotherapy efficacy through innovative nanotechnology: Narrative review\u201d"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9511-585X","authenticated-orcid":false,"given":"Mohsen","family":"Shafiee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9625-2154","authenticated-orcid":false,"given":"Elahe","family":"Soltani Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3748-382X","authenticated-orcid":false,"given":"Sina","family":"Taghvimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0576-4435","authenticated-orcid":false,"given":"Ahmad","family":"Movahedpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5654-7561","authenticated-orcid":false,"given":"Pegah","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4525-0025","authenticated-orcid":false,"given":"Seyed Masoud","family":"Rezaeijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8579-5097","authenticated-orcid":false,"given":"Seyyed Hossein","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1272-4121","authenticated-orcid":false,"given":"Omid","family":"Azadbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.apradiso.2025.111671_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/oxfordjournals.bmb.a070956","article-title":"Chemical radiosensitization of hypoxic cells","volume":"29","author":"Adams","year":"1973","journal-title":"Br. Med. Bull."},{"issue":"42","key":"10.1016\/j.apradiso.2025.111671_bib2","doi-asserted-by":"crossref","first-page":"14561","DOI":"10.1039\/C7DT00383H","article-title":"Mangiferin functionalized radioactive gold nanoparticles (MGF-(198)AuNPs) in prostate tumor therapy: green nanotechnology for production, in vivo tumor retention and evaluation of therapeutic efficacy","volume":"46","author":"Al-Yasiri","year":"2017","journal-title":"Dalton Trans."},{"issue":"7","key":"10.1016\/j.apradiso.2025.111671_bib3","doi-asserted-by":"crossref","first-page":"14800","DOI":"10.3390\/ijms140714800","article-title":"Molecularly targeted agents as radiosensitizers in cancer therapy\u2014focus on prostate cancer","volume":"14","author":"Alcorn","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.apradiso.2025.111671_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2041-9414-3-2","article-title":"Differential regulation of intracellular factors mediating cell cycle, DNA repair and inflammation following exposure to silver nanoparticles in human cells","volume":"3","author":"AshaRani","year":"2012","journal-title":"Genome Integr."},{"issue":"9","key":"10.1016\/j.apradiso.2025.111671_bib5","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1023\/A:1012258723075","article-title":"Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer","volume":"12","author":"Beer","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.apradiso.2025.111671_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.991330","article-title":"Advances and development of prostate cancer, treatment, and strategies: a systemic review","volume":"10","author":"Belkahla","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.apradiso.2025.111671_bib7","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJMoa043739","article-title":"Radical prostatectomy versus watchful waiting in early prostate cancer","volume":"352","author":"Bill-Axelson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.apradiso.2025.111671_bib8","series-title":"Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer","first-page":"2012","author":"Bonkhoff","year":"2012"},{"issue":"40","key":"10.1016\/j.apradiso.2025.111671_bib9","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1021\/jp075253u","article-title":"Nanoscale energy deposition by X-ray absorbing nanostructures","volume":"111","author":"Carter","year":"2007","journal-title":"J. Phys. Chem. B"},{"issue":"50","key":"10.1016\/j.apradiso.2025.111671_bib10","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/aae272","article-title":"A gold nanoparticle system for the enhancement of radiotherapy and simultaneous monitoring of reactive-oxygen-species formation","volume":"29","author":"Choi","year":"2018","journal-title":"Nanotechnology"},{"key":"10.1016\/j.apradiso.2025.111671_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/751075","article-title":"Noble metal nanoparticles applications in cancer","volume":"2012","author":"Conde","year":"2012","journal-title":"J. Drug Delivery"},{"issue":"9","key":"10.1016\/j.apradiso.2025.111671_bib12","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1039\/D0CS01127D","article-title":"Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine","volume":"50","author":"de Almeida","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.apradiso.2025.111671_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3816\/CGC.2002.n.018","article-title":"Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a prospective randomized multicenter trial","volume":"1","author":"de Leval","year":"2002","journal-title":"Clin. Prostate. Cancer"},{"issue":"2","key":"10.1016\/j.apradiso.2025.111671_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajur.2018.11.007","article-title":"Diagnosis of prostate cancer","volume":"6","author":"Descotes","year":"2019","journal-title":"Asian J. Urology"},{"issue":"4","key":"10.1016\/j.apradiso.2025.111671_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0305-7372(76)80012-6","article-title":"Radiosensitizers of hypoxic cells in solid tumours","volume":"3","author":"Fowler","year":"1976","journal-title":"Cancer Treat Rev."},{"issue":"4","key":"10.1016\/j.apradiso.2025.111671_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4161\/cbt.23626","article-title":"Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells","volume":"14","author":"Gandhi","year":"2013","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.apradiso.2025.111671_bib17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3332\/ecancer.2017.785","article-title":"Recent advances in radiation oncology","volume":"11","author":"Garibaldi","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.apradiso.2025.111671_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000473739","article-title":"Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience","volume":"29","author":"Gelet","year":"1996","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111671_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.urology.2013.01.072","article-title":"Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era","volume":"82","author":"Glass","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.apradiso.2025.111671_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1464-410X.2007.06598.x","article-title":"Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality\u2010of\u2010life issues","volume":"99","author":"Gomella","year":"2007","journal-title":"BJU Int."},{"issue":"5","key":"10.1016\/j.apradiso.2025.111671_bib21","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.urology.2009.03.003","article-title":"Current prostate cancer treatments: effect on quality of life","volume":"73","author":"Gomella","year":"2009","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.apradiso.2025.111671_bib22","first-page":"372","article-title":"Cryosurgical treatment of the prostate","volume":"3","author":"Gonder","year":"1966","journal-title":"Invest. Urol."},{"key":"10.1016\/j.apradiso.2025.111671_bib23","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2147\/IJN.S290438","article-title":"Application of radiosensitizers in cancer radiotherapy","volume":"16","author":"Gong","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"27","key":"10.1016\/j.apradiso.2025.111671_bib24","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1200\/JCO.2007.15.1233","article-title":"Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy","volume":"26","author":"Greenspan","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"4 Part 1","key":"10.1016\/j.apradiso.2025.111671_bib25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/01.ju.0000087860.52991.a8","article-title":"Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience","volume":"170","author":"Han","year":"2003","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.apradiso.2025.111671_bib26","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0022-5347(05)65742-4","article-title":"Gene therapy for prostate cancer: current status and future prospects","volume":"166","author":"Harrington","year":"2001","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.apradiso.2025.111671_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.21147\/j.issn.1000-9604.2022.03.07","article-title":"National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)","volume":"34","year":"2022","journal-title":"Chin. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111671_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eururo.2007.09.002","article-title":"EAU guidelines on prostate cancer","volume":"53","author":"Heidenreich","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.apradiso.2025.111671_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.addr.2015.12.012","article-title":"Gold nanoparticles for applications in cancer radiotherapy: mechanisms and recent advancements","volume":"109","author":"Her","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.apradiso.2025.111671_bib30","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1080\/09553000050151637","article-title":"Gold microspheres: a selective technique for producing biologically effective dose enhancement","volume":"76","author":"Herold","year":"2000","journal-title":"Int. J. Radiat. Biol."},{"issue":"23","key":"10.1016\/j.apradiso.2025.111671_bib31","doi-asserted-by":"crossref","first-page":"13549","DOI":"10.1073\/pnas.2232479100","article-title":"Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance","volume":"100","author":"Hirsch","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.apradiso.2025.111671_bib32","unstructured":"Huwaidi A. Response of DNA and Cells to Secondary Low-Energy Electrons Emitted from Gold Nanoparticles: Relationship to Cancer Targeted Radiotherapy."},{"issue":"2","key":"10.1016\/j.apradiso.2025.111671_bib33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.juro.2007.09.028","article-title":"Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy","volume":"179","author":"Israeli","year":"2008","journal-title":"J. Urol."},{"key":"10.1016\/j.apradiso.2025.111671_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.955925","article-title":"Systemic triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review and network meta-analysis","volume":"13","author":"Jian","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.apradiso.2025.111671_bib35","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamaoncol.2015.2316","article-title":"Dose-escalated irradiation and overall survival in men with nonmetastatic prostate cancer","volume":"1","author":"Kalbasi","year":"2015","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111671_bib36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/wnan.161","article-title":"Functionalized radioactive gold nanoparticles in tumor therapy","volume":"4","author":"Kannan","year":"2012","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"7","key":"10.1016\/j.apradiso.2025.111671_bib37","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/pros.20394","article-title":"Complete regression of experimental prostate cancer in nude mice by repeated hyperthermia using magnetite cationic liposomes and a newly developed solenoid containing a ferrite core","volume":"66","author":"Kawai","year":"2006","journal-title":"Prostate"},{"issue":"12","key":"10.1016\/j.apradiso.2025.111671_bib38","first-page":"1269","article-title":"Treatment options for localized prostate cancer","volume":"59","author":"Keyes","year":"2013","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.apradiso.2025.111671_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122499","article-title":"Synergistic therapeutic strategies and engineered nanoparticles for anti-vascular endothelial growth factor therapy in cancer","author":"Khafaga","year":"2024","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.apradiso.2025.111671_bib40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/09553002.2014.888104","article-title":"The role of iron oxide nanoparticles in the radiosensitization of human prostate carcinoma cell line DU145 at megavoltage radiation energies","volume":"90","author":"Khoei","year":"2014","journal-title":"Int. J. Radiat. Biol."},{"issue":"1\u20133","key":"10.1016\/j.apradiso.2025.111671_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mrrev.2010.01.002","article-title":"Enhancement of radiation effect by heavy elements","volume":"704","author":"Kobayashi","year":"2010","journal-title":"Mutat. Res."},{"issue":"9","key":"10.1016\/j.apradiso.2025.111671_bib42","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/molecules22091445","article-title":"Unique roles of gold nanoparticles in drug delivery, targeting and imaging applications","volume":"22","author":"Kong","year":"2017","journal-title":"Molecules"},{"issue":"Suppl. 5","key":"10.1016\/j.apradiso.2025.111671_bib43","first-page":"S37","article-title":"Adverse events associated with hormonal therapy for prostate cancer","volume":"7","author":"Kumar","year":"2005","journal-title":"Rev. Urol."},{"key":"10.1016\/j.apradiso.2025.111671_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2022.02.026","article-title":"Redox-responsive nanoparticles enhance radiation therapy by altering multifaceted radio-resistance mechanisms in human castration-resistant prostate cancer cells and xenografts","volume":"170","author":"Lip","year":"2022","journal-title":"Radiother. Oncol."},{"issue":"7","key":"10.1016\/j.apradiso.2025.111671_bib45","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.7150\/thno.22172","article-title":"Metal-based NanoEnhancers for future radiotherapy: radiosensitizing and synergistic effects on tumor cells","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.apradiso.2025.111671_bib46","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1021\/acs.nanolett.0c02487","article-title":"Targeted radiosensitizers for MR-guided radiation therapy of prostate cancer","volume":"20","author":"Luo","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.apradiso.2025.111671_bib47","series-title":"Seminars in Nuclear Medicine","article-title":"Preclinical assessment of strategies for enhancement of metaiodobenzylguanidine therapy of neuroendocrine tumors","author":"Mairs","year":"2011"},{"issue":"1","key":"10.1016\/j.apradiso.2025.111671_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0360-3016(00)01463-2","article-title":"Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report","volume":"49","author":"Martinez","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111671_bib49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2307\/3575225","article-title":"Iodine contrast medium sensitizes cultured mammalian cells to X rays but not to gamma rays","volume":"84","author":"Matsudaira","year":"1980","journal-title":"Radiat. Res."},{"key":"10.1016\/j.apradiso.2025.111671_bib50","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.msec.2014.10.062","article-title":"ZnFe2O4 nanoparticles as radiosensitizers in radiotherapy of human prostate cancer cells","volume":"46","author":"Meidanchi","year":"2015","journal-title":"Mater. Sci. Eng. C"},{"issue":"5","key":"10.1016\/j.apradiso.2025.111671_bib51","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/jbm.a.35300","article-title":"Polymeric nanoparticles for targeted radiosensitization of prostate cancer cells","volume":"103","author":"Menon","year":"2015","journal-title":"J. Biomed. Mater. Res."},{"issue":"6","key":"10.1016\/j.apradiso.2025.111671_bib52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.rpor.2010.09.001","article-title":"A review on gold nanoparticles radiosensitization effect in radiation therapy of cancer","volume":"15","author":"Mesbahi","year":"2010","journal-title":"Rep. Practical Oncol. Radiother."},{"issue":"3","key":"10.1016\/j.apradiso.2025.111671_bib53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/aja.aja_40_17","article-title":"Role of chemotherapy in prostate cancer","volume":"20","author":"Nader","year":"2018","journal-title":"Asian J. Androl."},{"issue":"6","key":"10.1016\/j.apradiso.2025.111671_bib54","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1172\/JCI45109","article-title":"Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts","volume":"121","author":"Ni","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111671_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2011.08.026","article-title":"Contemporary role of androgen deprivation therapy for prostate cancer","volume":"61","author":"Pagliarulo","year":"2012","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111671_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2490-13-4","article-title":"Radiosensitization in prostate cancer: mechanisms and targets","volume":"13","author":"Palacios","year":"2013","journal-title":"BMC Urol."},{"issue":"11","key":"10.1016\/j.apradiso.2025.111671_bib57","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1007\/s12274-020-2957-8","article-title":"Nanoparticles for targeted cancer radiotherapy","volume":"13","author":"Pallares","year":"2020","journal-title":"Nano Res."},{"issue":"23","key":"10.1016\/j.apradiso.2025.111671_bib58","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1200\/JCO.2000.18.23.3904","article-title":"Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer","volume":"18","author":"Pollack","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.apradiso.2025.111671_bib59","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bbrc.2015.09.027","article-title":"Metals as radio-enhancers in oncology: the industry perspective","volume":"468","author":"Pottier","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111671_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/187221107779814104","article-title":"Engineered nanoparticles in cancer therapy","volume":"1","author":"Praetorius","year":"2007","journal-title":"Recent Pat. Drug Deliv. Formulation"},{"issue":"2","key":"10.1016\/j.apradiso.2025.111671_bib61","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/09553002.2017.1231946","article-title":"Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells","volume":"93","author":"Rae","year":"2017","journal-title":"Int. J. Radiat. Biol."},{"issue":"3","key":"10.1016\/j.apradiso.2025.111671_bib62","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41416-021-01677-3","article-title":"MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data","volume":"126","author":"Rana","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.apradiso.2025.111671_bib63","series-title":"Developing Novel Carbon Nanomaterials for Tumor Imaging and Photothermal Therapy","author":"Robinson","year":"2012"},{"key":"10.1016\/j.apradiso.2025.111671_bib64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000475067","article-title":"The final analysis of the EORTC Genito-Urinary Group Phase III clinical trial (Protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate","volume":"28","author":"Robinson","year":"1995","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111671_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-9-225","article-title":"Molecular fingerprinting of radiation resistant tumors: can we apprehend and rehabilitate the suspects?","volume":"9","author":"Rosser","year":"2009","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.apradiso.2025.111671_bib66","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0022-5347(17)35032-2","article-title":"Demonstration of a rational strategy for human prostate cancer gene therapy","volume":"151","author":"Sanda","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.apradiso.2025.111671_bib67","first-page":"1","article-title":"Brief overview of prostate cancer statistics, grading, diagnosis and treatment strategies","author":"Schatten","year":"2018","journal-title":"Cell & Molecular Biology of Prostate Cancer"},{"issue":"2 Suppl. 1","key":"10.1016\/j.apradiso.2025.111671_bib68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0090-4295(02)02395-6","article-title":"National Comprehensive Cancer Network guidelines for the management of prostate cancer","volume":"61","author":"Scherr","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.apradiso.2025.111671_bib69","series-title":"Molecular & Diagnostic Imaging in Prostate Cancer","first-page":"87","article-title":"Multiparametric MRI and MRI\/TRUS fusion guided biopsy for the diagnosis of prostate cancer","author":"Sch\u00fctz","year":"2018"},{"issue":"17","key":"10.1016\/j.apradiso.2025.111671_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: Genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.apradiso.2025.111671_bib71","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-5347(05)67127-3","article-title":"Gene therapy for prostate cancer: where are we NOW?","volume":"164","author":"Steiner","year":"2000","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.apradiso.2025.111671_bib72","first-page":"86","article-title":"Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy","volume":"11","author":"Su","year":"2014","journal-title":"Cancer Biol. Med."},{"issue":"6","key":"10.1016\/j.apradiso.2025.111671_bib73","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1200\/JCO.1996.14.6.1756","article-title":"Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points","volume":"14","author":"Tannock","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.apradiso.2025.111671_bib74","article-title":"Nano therapeutic approaches to combat progression of metastatic prostate cancer","volume":"2","author":"Thakur","year":"2021","journal-title":"Adv. Cancer Biol. Metas."},{"issue":"6","key":"10.1016\/j.apradiso.2025.111671_bib75","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.juro.2007.03.003","article-title":"Guideline for the management of clinically localized prostate cancer: 2007 update","volume":"177","author":"Thompson","year":"2007","journal-title":"J. Urol."},{"issue":"8","key":"10.1016\/j.apradiso.2025.111671_bib76","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/089277903322518699","article-title":"High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study","volume":"17","author":"Th\u00fcroff","year":"2003","journal-title":"J. Endourol."},{"issue":"1B","key":"10.1016\/j.apradiso.2025.111671_bib77","first-page":"551","article-title":"Prostate cancer therapy: standard management, new options and experimental approaches","volume":"25","author":"Trojan","year":"2005","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111671_bib78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tips.2017.11.003","article-title":"Cancer radiosensitizers","volume":"39","author":"Wang","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.apradiso.2025.111671_bib79","first-page":"210","article-title":"Prostate cancer immunotherapy: a review of recent advancements with novel treatment methods and efficacy","volume":"10","author":"Wang","year":"2022","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.apradiso.2025.111671_bib80","series-title":"dbCRSR: a Manually Curated Database for Regulation of Cancer Radiosensitivity","first-page":"2018","author":"Wen","year":"2018"},{"issue":"2","key":"10.1016\/j.apradiso.2025.111671_bib81","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1569-9056(03)80537-7","article-title":"Cryoablation of primary and secondary prostate cancer using a 3rd generation cryo-technology: preliminary results","volume":"1","author":"Witzsch","year":"2003","journal-title":"Eur. Urol. Suppl."},{"issue":"5","key":"10.1016\/j.apradiso.2025.111671_bib82","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.nano.2014.12.016","article-title":"Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo","volume":"11","author":"Wolfe","year":"2015","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/j.apradiso.2025.111671_bib83","doi-asserted-by":"crossref","first-page":"E160","DOI":"10.25011\/cim.v31i3.3473","article-title":"Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles","volume":"31","author":"Zhang","year":"2008","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.apradiso.2025.111671_bib84","article-title":"Moving beyond traditional therapies: the role of nanomedicines in lung cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.apradiso.2025.111671_bib85","first-page":"147","article-title":"Cryosurgery of the prostate: techniques and pitfalls","volume":"23","author":"Zippe","year":"1996","journal-title":"Urologic Clin."}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804325000168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804325000168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:33:52Z","timestamp":1740461632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804325000168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":85,"alternative-id":["S0969804325000168"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2025.111671","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cNanoparticle-based sensitizers in prostate cancer treatment: Enhancing radiotherapy efficacy through innovative nanotechnology: Narrative review\u201d","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2025.111671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111671"}}